Project Grant R41NS103698

Oculomotor Technologies Inc. was awarded a $1,000,000 cooperative agreement from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a novel system for diagnosis of vision disorders. The two-year award, issued on May 1, 2021 with a completion date of April 30, 2023, will support Oculomotor Technologies' efforts to advance science and engineering research leading to breakthrough technologies for solutions to national...

This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $100,000 aims to develop a computational solution to evaluate optic nerve function. Specifically, the University of Nevada, Reno will use the funding to potentially create an affordable, convenient head-mounted display capable of remotely and routinely assessing the health of the optic nerve through afferent pupillary defect tests. This screening tool may allow doctors, including...

This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports the development of innovative deep learning-based biomarkers for the diagnosis and management of optic neuropathies using optical coherence tomography (OCT) imaging. The $179,964 award to the University of California, Irvine aims to: 1) employ deep generative models to map structure-function relationships and predict visual field outcomes for optic neuropathies;...

This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), aims to develop a novel, non-invasive, and sensitive diagnostic method for measuring retinal dysfunction. The $491,466 award, effective January 1, 2025 through December 31, 2026, will support research to expand the use of a visually-evoked compensatory behavior called the optokinetic reflex (OKR) for the detection and monitoring of localized cone and inner retinal...

This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is providing $306,462 to Ifocus Imaging LLC to develop a software platform called OCT-ART-DR. The platform will automate the diagnosis and staging of diabetic retinopathy using optical coherence tomography angiography (OCTA) imaging and artificial intelligence. The key products to be delivered under this award include: 1) Improved AI-based segmentation of OCTA image...

The National Eye Institute (NEI) awarded a $295,766 Project Grant (CFDA 93.867 - Vision Research) to Ther-Ai LLC, located in Oviedo, FL, to develop a smartphone application called ILIGN. The goal of this project is to create a rapid, non-invasive, and accurate artificial intelligence-driven system to pre-screen for ocular misalignment (strabismus), a leading cause of preventable blindness in children. The expected outcome is a software platform that allows untrained end-users to diagnose...

This Project Grant award from the National Institute on Disability, Independent Living, and Rehabilitation Research (CFDA 93.433) provides $1,499,997 to the University of Washington to conduct a clinical trial evaluating the efficacy of a novel rehabilitation intervention called Tools for Recovery and Clinical Care (ON-TRACC) in improving quality of life and function for individuals with persistent post-concussive symptoms following mild traumatic brain injury. The study aims to determine if...

This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I award, under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), provides $275,000 to Envision Health Technologies Inc. to develop a novel adaptive perimetry software solution for the early detection and monitoring of vision loss due to glaucoma. The project aims to create a fully automated adaptive perimetry test that combines the standardization of static automated perimetry (SAP)...

This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), is supporting research to develop and validate a novel method for measuring ocular pulse amplitude (OPA) using applanation-based tonometers. The award, totaling $245,243, will be used to pursue two specific aims: 1) validate the OPA measurement approach on non-human primates with implanted intraocular pressure telemetry systems, and 2) assess the repeatability and...

This $1,000,000 Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) will support the development of a gaze-independent, contactless autorefractor technology for use in a self-serve, autonomous vision exam kiosk. The project aims to improve access to vision care and eyeglasses for Americans by providing a rapid, convenient vision assessment solution that can be deployed in retail stores and public spaces. Key...